Publication:
The ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer

dc.contributor.authorÇubukcu, Erdem
dc.contributor.authorŞahin, Ahmet Bilgehan
dc.contributor.authorAtalay, Fatma Öz
dc.contributor.authorOcak, Birol
dc.contributor.authorÖzşen, Mine
dc.contributor.authorAbakay, Candan Demiröz
dc.contributor.authorÖzerkan, Kemal
dc.contributor.authorHasanzade, Ulviyya
dc.contributor.authorMesahorlı, Merve
dc.contributor.authorDeligönül, Adem
dc.contributor.authorOzan, Hakan
dc.contributor.authorEvrensel, Türkkan
dc.contributor.buuauthorÇUBUKÇU, ERDEM
dc.contributor.buuauthorŞAHİN, AHMET BİLGEHAN
dc.contributor.buuauthorÖZ ATALAY, FATMA
dc.contributor.buuauthorOCAK, BİROL
dc.contributor.buuauthorÖZŞEN, MİNE
dc.contributor.buuauthorDEMİRÖZ ABAKAY, CANDAN
dc.contributor.buuauthorÖZERKAN, KEMAL
dc.contributor.buuauthorHASANZADE, ULVIYYA
dc.contributor.buuauthorMesahorlı, Merve
dc.contributor.buuauthorDELİGÖNÜL, ADEM
dc.contributor.buuauthorOZAN, HAKAN
dc.contributor.buuauthorEVRENSEL, TÜRKKAN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı.
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Jinekolojik Onkoloji Anabilim Dalı.
dc.contributor.orcid0000-0002-7846-0870
dc.contributor.orcid0000-0001-7537-1699
dc.contributor.orcid0000-0002-5771-7649
dc.contributor.orcid0000-0001-5380-5898
dc.contributor.researcheridAAH-9791-2021
dc.contributor.researcheridK-2269-2016
dc.contributor.researcheridAAM-4927-2020
dc.contributor.researcheridETP-1691-2022
dc.contributor.researcheridJHC-4482-2023
dc.contributor.researcheridHHA-1866-2022
dc.contributor.researcheridAAI-1609-2021
dc.contributor.researcheridAAH-3855-2021
dc.contributor.researcheridEXU-7466-2022
dc.contributor.researcheridFNB-4540-2022
dc.contributor.researcheridESM-4544-2022
dc.contributor.researcheridDKZ-4159-2022
dc.contributor.researcheridEXJ-0967-2022
dc.date.accessioned2024-06-25T11:31:50Z
dc.date.available2024-06-25T11:31:50Z
dc.date.issued2021-04-21
dc.description.abstractObjective: To investigate the prognostic factors comparing clinical, histopathological, and laboratory parameters in low-risk endometrial cancer (EC). Methods: In the present single-center study, multivariate Cox regression analysis was performed on retrospective clinical and laboratory data and histopathological features obtained from the re-evaluation of 253 patients with low-risk EC. Receiver operating characteristic curves (ROC) were plotted for neutrophile-lymphocyte ratio (NLR), platelet-lymphocyte ratio, lymphocyte-monocyte ratio and Ki-67 index for recurrence. Kaplan-Meier analysis was employed for survival rates. Results: The median age was 58.5 years (32.0-75.4). Most of the patients were obese and post-menopausal. In nearly half of the patients, lymphadenectomy was performed in addition to hysterectomy and oophorectomy. The median tumor size was 30 mm (range 2-80), and the median Ki-67 index was 25 (1-90). According to the ROC curve analysis, the cut-off values for the Ki-67 index, NLR, PLR, and LMR were determined as >= 22, >= 1.98, >= 115.3, and >= 4.71, respectively. The log-rank test revealed that the patients with a Ki67 index lower than 22% and NLR lower than 1.98 had statistically longer recurrence-free survival (RFS) (p = 0.002 for Ki-67 index and p = 0.004 for NLR). The multivariate analysis revealed that the Ki-67 index and NLR were statistically significant factors for RFS (p = 0.012 and p = 0.029, respectively). Conclusion: The present study highlights the prognostic implications of both the Ki-67 index and NLR in lowrisk EC.
dc.identifier.doi10.31083/j.ejgo4204117
dc.identifier.eissn2709-0086
dc.identifier.endpage781
dc.identifier.issn0392-2936
dc.identifier.issue4
dc.identifier.startpage775
dc.identifier.urihttps://doi.org/10.31083/j.ejgo4204117
dc.identifier.urihttps://www.ejgo.net/articles/10.31083/j.ejgo4204117
dc.identifier.urihttps://hdl.handle.net/11452/42369
dc.identifier.volume42
dc.identifier.wos000686639400024
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherMre Press
dc.relation.journalEuropean Journal of Gynaecological Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCell proliferation
dc.subjectExpression
dc.subjectImpact
dc.subjectRoles
dc.subjectKi67
dc.subjectP53
dc.subjectPR
dc.subjectER
dc.subjectEndometrial cancer
dc.subjectLow-risk
dc.subjectKi-67
dc.subjectNLR
dc.subjectSurvival
dc.subjectOncology
dc.subjectObstetrics & gynecology
dc.titleThe ki-67 index and neutrophile-lymphocyte ratio are prognostic factors in patients with low-risk endometrial cancer
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationf971677f-09c5-4463-bf01-3c6341fbe5f7
relation.isAuthorOfPublication4dc703eb-05b2-4b24-b6ad-dcaca00b36d9
relation.isAuthorOfPublication1ce7be89-9690-438f-b756-18b50aad8607
relation.isAuthorOfPublication2f0a7090-a0f8-4520-aa3f-0171466752bd
relation.isAuthorOfPublication736328be-f008-46e1-825a-46199f11dad9
relation.isAuthorOfPublication42e5fe2e-88cd-4083-9ed8-28b4cfa73e9d
relation.isAuthorOfPublication47fb1174-c9d0-40fc-bb18-53e5b1eb1df2
relation.isAuthorOfPublication242ca593-b508-41f1-b6e4-a45dee33c95e
relation.isAuthorOfPublicationedfc19d5-ce9e-4fbd-8a24-07492003c264
relation.isAuthorOfPublication9dfbd47f-e25c-496c-ad06-d28af10bd48c
relation.isAuthorOfPublicationeceff514-6af7-4c3b-a146-b77546565a6c
relation.isAuthorOfPublication.latestForDiscoveryf971677f-09c5-4463-bf01-3c6341fbe5f7

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Çubukcu_vd_2021.pdf
Size:
1.86 MB
Format:
Adobe Portable Document Format

Collections